BRITANNIA LIFE SCIENCES (L020) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BRITANNIA LIFE SCIENCES (L020) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€989.01K ≈ $1.16 Million USD) by net assets (€17.23 Million ≈ $20.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see L020 market cap overview for the company's overall valuation and market capitalisation.
BRITANNIA LIFE SCIENCES - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how BRITANNIA LIFE SCIENCES's cash flow conversion efficiency has evolved over time, based on yearly financial data.
BRITANNIA LIFE SCIENCES Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BRITANNIA LIFE SCIENCES ranked by their cash flow conversion efficiency. Explore L020 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Great Western Exploration Ltd
AU:GTE
|
-0.036x |
|
ConnectM Technology Solutions, Inc.
NASDAQ:CNTM
|
0.098x |
|
Diriteks Dirilis Tekstil Sanayi ve Ticaret AS
IS:DIRIT
|
-0.030x |
|
Computer Forms (Malaysia) Bhd
KLSE:8044
|
-0.108x |
|
TOP Ships Inc.
NYSE MKT:TOPS
|
0.081x |
|
Methanor
PA:ALMET
|
13.967x |
|
Nitro Games Oyj
ST:NITRO
|
0.317x |
|
YGL Convergence Bhd
KLSE:0086
|
0.001x |
Annual Cash Flow Conversion Efficiency for BRITANNIA LIFE SCIENCES (2022–2025)
The table below shows the annual cash flow conversion efficiency of BRITANNIA LIFE SCIENCES from 2022 to 2025. View BRITANNIA LIFE SCIENCES stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | €6.30 Million ≈ $7.37 Million |
€-2.62 Million ≈ $-3.06 Million |
-0.416x | -232.59% |
| 2024-03-31 | €6.67 Million ≈ $7.80 Million |
€2.09 Million ≈ $2.45 Million |
0.314x | +72.71% |
| 2023-03-31 | €11.06 Million ≈ $12.93 Million |
€2.01 Million ≈ $2.35 Million |
0.182x | -64.44% |
| 2022-03-31 | €5.48 Million ≈ $6.41 Million |
€2.80 Million ≈ $3.27 Million |
0.511x | -- |
About BRITANNIA LIFE SCIENCES
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.